-+ 0.00%
-+ 0.00%
-+ 0.00%

RBC Capital Maintains Sector Perform on Pliant Therapeutics, Lowers Price Target to $3

Benzinga·03/04/2025 15:30:41
Listen to the news
RBC Capital analyst Brian Abrahams maintains Pliant Therapeutics (NASDAQ:PLRX) with a Sector Perform and lowers the price target from $4 to $3.